Warning: The NCBI web site requires JavaScript to function. more...
Dermatology Department, Baylor College of Medicine, and Houston Veterans Affairs Medical Center, Texas, USA.
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate. However, a better understanding of the basic immunopathogenic properties of sarcoidosis has elucidated a number of steps critical to the persistence and progression of disease that may be vulnerable to treatment by targeted therapy. This article reviews both standard and newer therapeutic options for cutaneous sarcoidosis.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on